Home Tags Phase III TULIP® trial

Tag: Phase III TULIP® trial

Trastuzumab Duocarmazine Granted U.S. FDA Fast Track Designation for Pre-treated HER2+...

The United States Food & Drug Administration (FDA) has granted Fast Track designation for The Netherlands-based Synthon Biopharmaceuticals investigational anti-HER2 antibody-drug conjugate or ADC...